Menu
 
Research menu
Jump to menu

Publications:  Mr Wayne Huttly

WALD NJ, LAU KW, BESTWICK J, Old R, HUTTLY W, CHENG R(2018). Specifying a Gold-Standard for the validation of fetal fraction estimation in prenatal screening. Clinical Chemistry vol. 64, (9) 1394-1399.
10.1373/clinchem.2018.288670
https://qmro.qmul.ac.uk/xmlui/handle/123456789/41143
BESTWICK JP, HUTTLY W, WALD N(2018). Serum marker truncation limits in first trimester antenatal screening for trisomy 18. Journal of Medical Screening
10.1177/0969141318783021
https://qmro.qmul.ac.uk/xmlui/handle/123456789/42863
Wald NJ, Huttly WJ, Bestwick JP, Old R, Morris JK, Cheng R, Aquilina J, Peregrine E et al.(2018). Response to Walker. Genet Med
10.1038/gim.2017.256
https://qmro.qmul.ac.uk/xmlui/handle/123456789/45953
WALD NJ, Huttly WJ, Bestwick JP, Old R, Morris JK, Cheng R, Aquilina J, Peregrine E et al.(2017). Prenatal reflex DNA screening for trisomy 21, 18, and 13. Genetics in Medicine
10.1038/gim.2017.188
https://qmro.qmul.ac.uk/xmlui/handle/123456789/28844
Bestwick JP, Huttly WJ, Wald NJ(2017). Pregnancy-associated plasma protein-A truncation limits in antenatal screening for trisomy 18. J Med Screen969141316688499-969141316688499.
10.1177/0969141316688499
Huttly WJ, Bestwick JP, Wald NJ(2016). Insulin dependent diabetes mellitus (IDDM) and first trimester markers in prenatal screening for Down syndrome. Prenatal Diagnosis vol. 36, (2) 192-193.
10.1002/pd.4722
Wald NJ, Huttly WJ, Bestwick JP, Aquilina J, Peregrine E(2015). Reflex antenatal DNA screening for Down syndrome. Prenatal Diagnosis vol. 35, (11) 1154-1154.
10.1002/pd.4658
Bestwick JP, Huttly WJ, Wald NJ(2015). Untitled. JOURNAL OF MEDICAL SCREENING vol. 22, (1) 52-54.
10.1177/0969141315571499
Bestwick JP, Huttly WJ, Wald NJ(2014). The estimation of median nuchal translucency values between 10 and 14 weeks of pregnancy. J Med Screen vol. 21, (2) 110-112.
10.1177/0969141314536890
Huttly W, Bestwick J, Wald N(2014). Effect of smoking status on inhibin-A in second-trimester prenatal screening for Down syndrome. Prenat Diagn vol. 34, (4) 406-407.
10.1002/pd.4313
Bestwick JP, Huttly WJ, Morris JK, Wald NJ(2014). Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women. PLoS One vol. 9, (2)
10.1371/journal.pone.0089354
https://qmro.qmul.ac.uk/xmlui/handle/123456789/15139
Bestwick JP, Huttly WJ, Wald NJ(2013). Detection of trisomy 18 and trisomy 13 using first and second trimester Down's syndrome screening markers. J Med Screen vol. 20, (2) 57-65.
10.1177/0969141313484904
Bestwick JP, Huttly WJ, Wald NJ(2013). Allowing for ethnic group in antenatal screening for Down's syndrome. J Med Screen vol. 20, (1) 52-54.
10.1177/0969141313486893
Wald NJ, Bestwick JP, Huttly WJ(2013). Improvements in antenatal screening for Down's syndrome. J Med Screen vol. 20, (1) 7-14.
10.1177/0969141313476496
Bestwick JP, Huttly WJ, Wald NJ(2013). Allowing for ethnic group in antenatal screening for Down's syndrome. JOURNAL OF MEDICAL SCREENING vol. 20, (1) 52-54.
10.1177/0969141313486893
Huttly WJ, Wald NJ(2012). The estimation of gestational age of pregnancy for use in screening for Down syndrome using ultrasound measurements and embryo transfer date. Prenat Diagn vol. 32, (10) 1008-1009.
10.1002/pd.3931
Wald NJ, Bestwick JP, Huttly WJ(2012). Effect of interrupting prenatal Down syndrome screening due to a large nuchal translucency. Prenat Diagn vol. 32, (7) 655-661.
10.1002/pd.3881
Bestwick JP, Huttly WJ, Wald NJ(2012). Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome. Prenatal Diagnosis vol. 32, (7)
10.1002/pd.3925
Bestwick JP, Huttly WJ, Wald NJ(2012). Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome. Prenat Diagn vol. 32, (3) 299-301.
10.1002/pd.2936
Wald NJ, Bestwick JP, George LM, Huttly WJ(2012). Antenatal screening for Down syndrome using serum placental growth factor with the combined, quadruple, serum integrated and integrated tests. PLoS One vol. 7, (10)
10.1371/journal.pone.0046955
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5480
Huttly WJ, Wald NJ(2011). An audit of the detection of trisomy 18 in prenatal screening for Down syndrome using the Combined test. Prenat Diagn vol. 31, (13)
10.1002/pd.2890
Filippi E, Staughton J, Peregrine E, Jones P, Huttly W, Peebles DM, Pandya P, David AL(2011). Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening. Ultrasound Obstet Gynecol vol. 37, (5) 520-527.
10.1002/uog.8901
Filippi E, Staughton J, Peregrine E, Jones P, Huttly W, Peebles D, Pandya P, David A(2010). Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of feto-placental proteins used for Down's syndrome screening. Ultrasound Obstet Gynecol
10.1002/uog.8901
Bestwick JP, Huttly WJ, Wald NJ(2010). Distribution of nuchal translucency in antenatal screening for Down's syndrome (vol 17, pg 8, 2010). J MED SCREEN vol. 17, (2) 106-106.
10.1258/jms.2010.010351
Bestwick JP, Huttly WJ, Wald NJ(2010). Distribution of nuchal translucency in antenatal screening for Down's syndrome. J Med Screen vol. 17, (1) 8-12.
10.1258/jms.2010.009107
Bestwick JP, Huttly WJ, Wald NJ(2010). Evaluation of a proposed mixture model to specify the distributions of nuchal translucency measurements in antenatal screening for Down's syndrome. J Med Screen vol. 17, (1) 13-18.
10.1258/jms.2010.009108
Wald NJ, Huttly WJ, Murphy KW, Ali K, Bestwick JP, Rodeck CH(2009). Antenatal screening for Down's syndrome using the Integrated test at two London hospitals. J Med Screen vol. 16, (1) 7-10.
10.1258/jms.2009.008094
Wald NJ, Huttly WJ, Bestwick JP(2008). Inhibin-A concentrations between 14 and 22 weeks of gestation. Prenat Diagn vol. 28, (4) 360-361.
10.1002/pd.1964
Bestwick JP, Huttly WJ, Wald NJ(2008). First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency. J Med Screen vol. 15, (4) 204-206.
10.1258/jms.2008.008049
Weisz B, Pandya PP, David AL, Huttly W, Jones P, Rodeck CH(2007). Ultrasound findings after screening for Down syndrome using the integrated test. Obstet Gynecol vol. 109, (5) 1046-1052.
10.1097/01.AOG.0000260234.20190.6e
Weisz B, Pandya P, Chitty L, Jones P, Huttly W, Rodeck C(2007). Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice. BJOG vol. 114, (4) 493-497.
10.1111/j.1471-0528.2007.01238.x
Huttly WJ, Morris JK, Bestwick JP, Wald NJ, Murphy K, Pandya PP(2006). Three stage contingent screening for Down syndrome. Prenat Diagn vol. 26, (12)
10.1002/pd.1579
Wald NJ, Barnes IM, Birger R, Huttly W(2006). Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy (vol 26, pg 539, 2006). PRENATAL DIAGNOSIS vol. 26, (6) 589-589.
10.1002/pd.1492
Wald NJ, Barnes IM, Birger R, Huttly W(2006). Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy. Prenat Diagn vol. 26, (6) 539-544.
10.1002/pd.1455
Wald NJ, Bestwick JP, Huttly WJ, Morris JK, George LM(2006). Validation plots in antenatal screening for Down's syndrome. J Med Screen vol. 13, (4) 166-171.
10.1177/096914130601300402
Wald NJ, Huttly WJ, Rudnicka AR(2004). Recurrent false-positives in AFP screening for open neural tube defects. Prenat Diagn vol. 24, (12) 1018-1019.
10.1002/pd.986
Huttly W, Rudnicka A, Wald NJ(2004). Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus. Prenat Diagn vol. 24, (10) 804-807.
10.1002/pd.994
RUDNICKA AR, Wald NJ, Huttly WJ(2004). Parental screening for Downs syndrome: the problem of recurrent false-positives. Prenatal Diagnosis. vol. 24, 389-392.
10.1002/pd.890
Rudnicka AR, WALD NJ, Huttly W(2004). Prenatal screening for Down syndrome: the problem of recurrent false-positives. Prenatal Diagnosis. vol. 24, (5) 389-392.
10.1002/pd.890
Alberman E, Huttly W, Hennessy E, McIntosh A(2003). The use of record linkage for auditing the uptake and outcome of prenatal serum screening and prenatal diagnostic tests for Down syndrome. Prenat Diagn vol. 23, (10) 801-806.
10.1002/pd.683
Wald NJ, Huttly WJ, Hackshaw AK(2003). Antenatal screening for Down's syndrome with the quadruple test. Lancet vol. 361, (9360) 835-836.
10.1016/S0140-6736(03)12680-3
Wald NJ, Huttly W, Hackshaw AK, Christiansen M, Larsen SO, Nørgaard-Pedersen B, Howe D, Wellesley D(2002). Antenatal screening policies for Down's syndrome [3] (multiple letters). British Medical Journal vol. 325, (7371) 1034-1035.
Wald NJ, Huttly W, Hackshaw AK(2002). Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid. BMJ vol. 325, (7371)
10.1136/bmj.325.7371.1034
Rudnicka AR, Wald NJ, Huttly W, Hackshaw AK(2002). Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. Prenat Diagn vol. 22, (10) 893-897.
10.1002/pd.440
Return to top